verrelst-herman

Herman Verrelst joined Biocartis as CEO in Sept 2017. Before that, he was active as VP & General Manager of the Genomics Division of Agilent Technologies Inc. (NYSE: A), a global leader in life sciences & diagnostics. In 2015, Agilent acquired Cartagenia, focused on software solutions for clinical genetics & molecular oncology, of which Herman was CEO and founder. Prior to that, Herman was CEO of Medicim (acquired by Nobel Biocare AG, 2007), and founder & CEO of DATA4s (acquired by NorkomTechnologies Ltd., 2004). Herman holds a Master’s degree in Electrical Engineering (Catholic University of Leuven, Belgium).